Physiological parameter values for physiologically based pharmacokinetic models

被引：1131

作者：

Brown, RP

Delp, MD

Lindstedt, SL

Rhomberg, LR

Beliles, RP

机构：

[1] US EPA, NATL CTR ENVIRONM ASSESSMENT 8623, WASHINGTON, DC 20460 USA

[2] INT LIFE SCI INST, RISK SCI INST, WASHINGTON, DC USA

[3] TEXAS A&M UNIV, DEPT HLTH & KINESIOL, COLLEGE STN, TX USA

[4] NO ARIZONA UNIV, DEPT BIOL SCI, FLAGSTAFF, AZ 86011 USA

[5] HARVARD UNIV, SCH PUBL HLTH, HARVARD CTR RISK ANAL, BOSTON, MA 02115 USA

来源：

TOXICOLOGY AND INDUSTRIAL HEALTH | 1997年 / 13卷 / 04期

关键词：

biological models; pharmacokinetics; physiological parameters;

D O I：

10.1177/074823379701300401

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：407 / 484

页数：78

共 239 条

[41] MEASUREMENT OF NORMAL PORTAL VENOUS-BLOOD FLOW BY DOPPLER ULTRASOUND [J].

BROWN, HS ;

HALLIWELL, M ;

QAMAR, M ;

READ, AE ;

EVANS, JM ;

WELLS, PNT .

GUT, 1989, 30 (04) :503-509

[42] HUMAN ADIPOSE-TISSUE BLOOD-FLOW DURING PROLONGED EXERCISE II [J].

BULOW, J ;

MADSEN, J .

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1978, 376 (01) :41-45

[43] HISTORY, SURVIVAL, AND GROWTH-PATTERNS OF B6C3F1 MICE AND F344 RATS IN THE NATIONAL CANCER INSTITUTE CARCINOGENESIS TESTING PROGRAM [J].

CAMERON, TP ;

HICKMAN, RL ;

KORNREICH, MR ;

TARONE, RE .

FUNDAMENTAL AND APPLIED TOXICOLOGY, 1985, 5 (03) :526-538

[44] ETHANOL-INDUCED INCREASE IN PORTAL BLOOD-FLOW - ROLE OF ACETATE AND A1-ADENOSINE AND A2-ADENOSINE RECEPTORS [J].

CARMICHAEL, FJ ;

SALDIVIA, V ;

VARGHESE, GA ;

ISRAEL, Y ;

ORREGO, H .

AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (04) :G417-G423

[45] SPLANCHNIC BLOOD-FLOW CHANGES IN THE PRESENCE OF HEPATIC TUMOR - EVIDENCE OF A HUMORAL MEDIATOR [J].

CARTER, R ;

ANDERSON, JH ;

COOKE, TG ;

BAXTER, JN ;

ANGERSON, WJ .

BRITISH JOURNAL OF CANCER, 1994, 69 (06) :1025-1026

[46] EFFECTS OF CLENBUTEROL ON SKELETAL-MUSCLE MASS, BODY-COMPOSITION, AND RECOVERY FROM SURGICAL STRESS IN SENESCENT RATS [J].

CARTER, WJ ;

DANG, AQ ;

FAAS, FH ;

LYNCH, ME .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (08) :855-860

[47]

CASTER WO, 1956, P SOC EXP BIOL MED, V91, P122, DOI 10.3181/00379727-91-22186

[48]

CLARYS JP, 1984, HUM BIOL, V56, P459

[49] INCORPORATION OF PHARMACOKINETICS IN NONCANCER RISK ASSESSMENT - EXAMPLE WITH CHLOROPENTAFLUOROBENZENE [J].

CLEWELL, HJ ;

JARNOT, BM .

RISK ANALYSIS, 1994, 14 (03) :265-276

[50]

CLEWELL HJ, 1994, COMMUNICATION

← 1 2 3 4 5 6 7 8 9 10 →